Income Statement Pulsenmore Ltd.

Stocks

PLSM

IL0011767006

Advanced Medical Equipment & Technology

End-of-day quote TEL AVIV STOCK EXCHANGE 2026-08-19			5-day change	1st Jan Change
902.40 ^ILa	+5.27%		-8.48%	-56.80%

08-17	Pulsenmore Ltd Receives Israel Innovation Authority Grant Of USD 1.27 Million For Smartscan AI Program	CI
07-13	Pulsenmore Selected For Israel Innovation Authority And Ministry Of Health Program To Lead $1 Million AI Development Project	CI

257310ab1f27e315b02e76fed5b.mvXUfstyqWIB7KysbLZf3FmEKhg1Mb5i5mgmTPrQntA.2JGxJoor5gh0jsGcAc9q6grsXld8eOcJrilnCrPnp4rdxJAzujXrNEerww

Published financial data: PULSENMORE LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.58M	10.81M	6.19M	9.66M	9.48M
Other Revenues, Total	-	-	-	-	30.54M
Total Revenues	1.58M	10.81M	6.19M	9.66M	40.02M
Cost of Goods Sold, Total	864K	5.69M	3.99M	6.08M	6.34M
Gross Profit	714K	5.12M	2.2M	3.58M	33.68M
Selling General & Admin Expenses, Total	11.81M	21.7M	26.39M	25.66M	28.5M
R&D Expenses	10.84M	29.62M	31.4M	20.13M	17.35M
Other Operating Expenses	6K	-	-	-	-
Other Operating Expenses, Total	22.66M	51.33M	57.79M	45.79M	45.85M
Operating Income	-21.94M	-46.2M	-55.59M	-42.22M	-12.16M
Interest Expense, Total	-267K	-323K	-586K	-502K	-315K
Interest And Investment Income	76K	3.09M	6.85M	5.32M	3.54M
Net Interest Expenses	-191K	2.77M	6.27M	4.82M	3.22M
Currency Exchange Gains (Loss)	-4.33M	10.62M	6.42M	552K	-5.56M
Other Non Operating Income (Expenses)	839K	10.7M	-15.55M	52K	-1.35M
EBT, Excl. Unusual Items	-25.62M	-22.12M	-58.44M	-36.79M	-15.85M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-25.62M	-22.12M	-58.44M	-36.79M	-15.85M
Income Tax Expense	-	-	127K	-56K	1K
Earnings From Continuing Operations	-25.62M	-22.12M	-58.57M	-36.74M	-15.85M
Net Income to Company	-25.62M	-22.12M	-58.57M	-36.74M	-15.85M
Net Income - (IS)	-25.62M	-22.12M	-58.57M	-36.74M	-15.85M
Net Income to Common Incl Extra Items	-25.62M	-22.12M	-58.57M	-36.74M	-15.85M
Net Income to Common Excl. Extra Items	-25.62M	-22.12M	-58.57M	-36.74M	-15.85M
Per Share Items
Net EPS - Basic	-5	-3.67	-9.15	-5.74	-2.46
Basic EPS - Continuing Operations	-5	-3.67	-9.15	-5.74	-2.46
Basic Weighted Average Shares Outstanding	5.13M	6.03M	6.4M	6.4M	6.44M
Net EPS - Diluted	-5	-3.68	-9.15	-5.76	-2.46
Diluted EPS - Continuing Operations	-5	-3.68	-9.15	-5.76	-2.46
Diluted Weighted Average Shares Outstanding	5.13M	6.03M	6.4M	6.4M	6.44M
Normalized Basic EPS	-3.12	-2.29	-5.7	-3.59	-1.54
Normalized Diluted EPS	-3.12	-2.29	-5.7	-3.59	-1.54
Supplemental Items
EBITDA	-21.77M	-45.79M	-54.19M	-40.37M	-10.33M
EBITA	-21.94M	-46.2M	-55.59M	-42.22M	-12.16M
EBIT	-21.94M	-46.2M	-55.59M	-42.22M	-12.16M
Total Revenues (As Reported)	-	-	-	-	40.02M
Effective Tax Rate - (Ratio)	-	-	-0.22	0.15	-0.01
Total Current Taxes	-	-	127K	-	-
Normalized Net Income	-16.02M	-13.82M	-36.52M	-23M	-9.91M
Interest on Long-Term Debt	267K	323K	586K	502K	315K
Supplemental Operating Expense Items
Advertising Expense	2.32M	3.56M	3.55M	4.27M	4.56M
Selling and Marketing Expenses	4.37M	8.92M	9.43M	10.32M	11.82M
General and Administrative Expenses	7.43M	12.79M	16.95M	15.34M	16.68M
Research And Development Expense From Footnotes	13.07M	29.62M	31.4M	20.13M	17.35M
Stock-Based Comp., R&D Exp. (Total)	776K	1.72M	879K	117K	108K
Stock-Based Comp., S&M Exp. (Total)	133K	255K	321K	144K	60K
Stock-Based Comp., G&A Exp. (Total)	1.95M	3.14M	2.25M	1.23M	472K
Stock-Based Comp., Other (Total)	-	-	-	-	27K
Total Stock-Based Compensation	2.86M	5.11M	3.45M	1.49M	667K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	113M	15.37M	23.87M	41.17M	21.6M
Short Term Investments	40.48M	168M	118M	62.85M	47.53M
Total Cash And Short Term Investments	153M	183M	142M	104M	69.14M
Accounts Receivable, Total	1.28M	9.93M	962K	3.91M	4.14M
Other Receivables	4.04M	1.44M	1.14M	652K	743K
Total Receivables	5.32M	11.37M	2.1M	4.56M	4.89M
Inventory	4.48M	14.25M	23.69M	23.09M	6.59M
Prepaid Expenses	-	-	-	293K	377K
Restricted Cash	140K	140K	140K	140K	140K
Other Current Assets, Total	2.07M	2.66M	236K	292K	271K
Total Current Assets	165M	212M	168M	132M	81.4M
Gross Property Plant And Equipment	2.58M	11.18M	16.5M	16.75M	17.36M
Accumulated Depreciation	-774K	-2.07M	-4.47M	-7.32M	-10.25M
Net Property Plant And Equipment	1.8M	9.12M	12.02M	9.42M	7.11M
Other Long-Term Assets, Total	-	15.6M	-	-	13.34M
Total Assets	167M	236M	180M	142M	102M
Liabilities
Accounts Payable, Total	830K	5.86M	4.92M	2.36M	1.98M
Accrued Expenses, Total	2.97M	3.67M	3.35M	5.77M	6.39M
Current Portion of Leases	554K	863K	923K	999K	1.02M
Other Current Liabilities	2.35M	5.16M	5.21M	5.14M	938K
Total Current Liabilities	6.71M	15.55M	14.41M	14.26M	10.33M
Long-Term Leases	232K	3.1M	2.41M	1.12M	542K
Other Non Current Liabilities	6.48M	30.14M	30.86M	29.56M	7.89M
Total Liabilities	13.43M	48.79M	47.68M	44.94M	18.76M
Common Stock, Total	1K	2K	2K	2K	2K
Additional Paid In Capital	201M	252M	252M	253M	256M
Retained Earnings	-49.87M	-71.98M	-131M	-167M	-183M
Comprehensive Income and Other	2.52M	7.22M	10.31M	10.97M	10.09M
Total Common Equity	154M	188M	132M	96.89M	83.09M
Total Equity	154M	188M	132M	96.89M	83.09M
Total Liabilities And Equity	167M	236M	180M	142M	102M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.78M	6.24M	6.24M	6.27M	6.5M
ECS Total Common Shares Outstanding	5.78M	6.24M	6.24M	6.27M	6.5M
Book Value / Share	26.58	30.05	21.19	15.45	12.78
Tangible Book Value	154M	188M	132M	96.89M	83.09M
Tangible Book Value Per Share	26.58	30.05	21.19	15.45	12.78
Total Debt	786K	3.97M	3.33M	2.12M	1.56M
Net Debt	-153M	-179M	-138M	-102M	-67.57M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	4.04M	14.08M	17.12M	17.98M	4.13M
Inventories - Work In Process, Total	218K	99K	702K	120K	334K
Inventories - Finished Goods, Total	219K	74K	5.87M	4.99M	2.13M
Machinery, Total	1.5M	5.96M	11.15M	11.66M	11.8M
Full Time Employees	47	64	67	58	71

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-25.62M	-22.12M	-58.57M	-36.74M	-15.85M
Depreciation & Amortization - CF	560K	1.3M	2.4M	2.85M	2.8M
Depreciation & Amortization, Total	560K	1.3M	2.4M	2.85M	2.8M
Stock-Based Compensation (CF)	2.04M	4.73M	3.28M	1.39M	667K
Other Operating Activities, Total	3.81M	-21.1M	2.83M	-5.42M	3.56M
Change In Accounts Receivable	-1.28M	-8.64M	8.96M	-2.95M	-235K
Change In Inventories	-2.61M	-9.77M	-9.44M	598K	3.16M
Change In Accounts Payable	162K	5.03M	-936K	-2.56M	-379K
Change in Unearned Revenues	2.29M	20.51M	157K	-	-27.09M
Change in Other Net Operating Assets	-5.37M	2.54M	1.65M	1.37M	491K
Cash from Operations	-26.03M	-27.52M	-49.66M	-41.46M	-32.88M
Capital Expenditure	-775K	-4.51M	-3.93M	-509K	-135K
Investment in Marketable and Equity Securities, Total	-40.48M	-123M	53.78M	51.42M	10.62M
Other Investing Activities, Total	-105K	2.5M	6.85M	7.67M	3.37M
Cash from Investing	-41.36M	-125M	56.71M	58.58M	13.85M
Long-Term Debt Repaid, Total	-512K	-188K	-994K	-1.17M	-1.18M
Total Debt Repaid	-512K	-188K	-994K	-1.17M	-1.18M
Issuance of Common Stock	174M	51.17M	2K	3K	25K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	4.53M	-17K	-152K	-400K	1.16M
Cash from Financing	178M	50.97M	-1.14M	-1.56M	4K
Foreign Exchange Rate Adjustments	-4.29M	3.62M	2.6M	1.74M	-542K
Net Change in Cash	107M	-97.49M	8.5M	17.3M	-19.57M
Supplemental Items
Cash Interest Paid	39K	1.1M	347K	292K	165K
Levered Free Cash Flow	-17.7M	-35.05M	-32.12M	-26.41M	7.69M
Unlevered Free Cash Flow	-17.54M	-34.84M	-31.75M	-26.1M	7.89M
Change In Net Working Capital	6.47M	7.87M	-1.06M	3.54M	-12.15M
Net Debt Issued / Repaid	-512K	-188K	-994K	-1.17M	-1.18M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-15.57	-14.31	-16.69	-16.4	-6.24
Return on Total Capital	-17.4	-16.69	-21.25	-22.5	-8.28
Return On Equity %	-32.72	-12.96	-36.63	-32.07	-17.62
Return on Common Equity	-32.72	-12.96	-36.63	-32.07	-17.62
Margin Analysis
Gross Profit Margin %	45.25	47.38	35.57	37.03	84.15
SG&A Margin	748.23	200.69	426.44	265.62	71.2
EBITDA Margin %	-1.38K	-423.46	-875.79	-417.91	-25.8
EBITA Margin %	-1.39K	-427.24	-898.29	-436.96	-30.39
EBIT Margin %	-1.39K	-427.24	-898.29	-436.96	-30.39
Income From Continuing Operations Margin %	-1.62K	-204.54	-946.46	-380.25	-39.61
Net Income Margin %	-1.62K	-204.54	-946.46	-380.25	-39.61
Net Avail. For Common Margin %	-1.62K	-204.54	-946.46	-380.25	-39.61
Normalized Net Income Margin	-1.01K	-127.84	-590.26	-238.02	-24.75
Levered Free Cash Flow Margin	-1.12K	-324.08	-519.08	-273.4	19.22
Unlevered Free Cash Flow Margin	-1.11K	-322.21	-513.16	-270.15	19.71
Asset Turnover
Asset Turnover	0.02	0.05	0.03	0.06	0.33
Fixed Assets Turnover	1.24	1.98	0.59	0.9	4.84
Receivables Turnover (Average Receivables)	-	1.93	1.14	3.97	2.36
Inventory Turnover (Average Inventory)	0.27	0.61	0.21	0.26	0.43
Short Term Liquidity
Current Ratio	24.64	13.61	11.65	9.28	7.88
Quick Ratio	23.65	12.51	9.98	7.61	7.17
Operating Cash Flow to Current Liabilities	-3.88	-1.77	-3.45	-2.91	-3.18
Days Sales Outstanding (Average Receivables)	-	189.22	321.14	92.27	154.96
Days Outstanding Inventory (Average Inventory)	1.34K	600.77	1.74K	1.41K	854.23
Average Days Payable Outstanding	78.65	78.99	146.57	242.94	-77.96
Cash Conversion Cycle (Average Days)	-	711	1.91K	1.26K	1.09K
Long Term Solvency
Total Debt/Equity	0.51	2.11	2.52	2.19	1.88
Total Debt / Total Capital	0.51	2.07	2.46	2.14	1.85
LT Debt/Equity	0.15	1.65	1.82	1.16	0.65
Long-Term Debt / Total Capital	0.15	1.62	1.78	1.13	0.64
Total Liabilities / Total Assets	8.03	20.65	26.5	31.69	18.42
EBIT / Interest Expense	-82.19	-143.04	-94.86	-84.09	-38.62
EBITDA / Interest Expense	-80.09	-139.03	-90.76	-78.41	-29.71
(EBITDA - Capex) / Interest Expense	-82.99	-152.98	-97.46	-79.43	-30.14
Total Debt / EBITDA	-0.04	-0.09	-0.06	-0.05	-0.17
Net Debt / EBITDA	7.13	3.99	2.6	2.59	7.22
Total Debt / (EBITDA - Capex)	-0.04	-0.08	-0.06	-0.05	-0.16
Net Debt / (EBITDA - Capex)	6.88	3.63	2.42	2.56	7.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	585.3	-42.78	56.12	314.28
Gross Profit, 1 Yr. Growth %	-	617.65	-57.05	62.52	841.63
EBITDA, 1 Yr. Growth %	128.63	110.39	18.35	-25.5	-74.42
EBITA, 1 Yr. Growth %	128.56	110.54	20.31	-24.05	-71.19
EBIT, 1 Yr. Growth %	128.56	110.54	20.31	-24.05	-71.19
Earnings From Cont. Operations, 1 Yr. Growth %	86.54	-13.68	164.78	-37.28	-56.85
Net Income, 1 Yr. Growth %	86.54	-13.68	164.78	-37.28	-56.85
Normalized Net Income, 1 Yr. Growth %	153.76	-13.68	164.21	-37.04	-56.91
Diluted EPS Before Extra, 1 Yr. Growth %	8.57	-26.36	149.48	-37.03	-57.1
Accounts Receivable, 1 Yr. Growth %	-	672.53	-90.31	306.34	6.01
Inventory, 1 Yr. Growth %	139.68	217.92	66.26	-2.52	-71.45
Net Property, Plant and Equip., 1 Yr. Growth %	144.97	405.55	31.9	-21.61	-24.59
Total Assets, 1 Yr. Growth %	1.76K	41.36	-23.87	-21.17	-28.19
Tangible Book Value, 1 Yr. Growth %	5.22K	21.98	-29.48	-26.73	-14.24
Common Equity, 1 Yr. Growth %	5.22K	21.98	-29.48	-26.73	-14.24
Cash From Operations, 1 Yr. Growth %	175.17	5.73	80.45	-16.52	-20.71
Capital Expenditures, 1 Yr. Growth %	99.23	481.42	-12.87	-87.04	-73.48
Levered Free Cash Flow, 1 Yr. Growth %	-	97.98	-8.35	-14.84	-129.12
Unlevered Free Cash Flow, 1 Yr. Growth %	-	98.71	-8.87	-14.85	-130.22
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	98.03	-5.48	154.32
Gross Profit, 2 Yr. CAGR %	-	-	75.57	-16.45	291.19
EBITDA, 2 Yr. CAGR %	-	119.32	57.79	-6.1	-56.35
EBITA, 2 Yr. CAGR %	-	119.37	59.16	-4.41	-53.22
EBIT, 2 Yr. CAGR %	-	119.37	59.16	-4.41	-53.22
Earnings From Cont. Operations, 2 Yr. CAGR %	-	26.89	51.18	28.87	-47.97
Net Income, 2 Yr. CAGR %	-	26.89	51.18	28.87	-47.97
Normalized Net Income, 2 Yr. CAGR %	-	48	51.02	28.97	-47.92
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-10.59	35.29	25.34	-48.13
Accounts Receivable, 2 Yr. CAGR %	-	-	-13.48	-37.25	107.55
Inventory, 2 Yr. CAGR %	-	176.04	129.9	27.3	-47.25
Net Property, Plant and Equip., 2 Yr. CAGR %	-	251.92	158.23	1.69	-23.12
Total Assets, 2 Yr. CAGR %	-	412.15	3.74	-22.53	-24.76
Tangible Book Value, 2 Yr. CAGR %	-	705.23	-7.26	-28.12	-20.73
Common Equity, 2 Yr. CAGR %	-	705.23	-7.26	-28.12	-20.73
Cash From Operations, 2 Yr. CAGR %	-	70.57	38.13	22.74	-18.64
Capital Expenditures, 2 Yr. CAGR %	-	240.35	125.07	-66.39	-81.46
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	34.7	-13.19	-50.21
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	34.57	-13.45	-49.27
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	82.94	54.68
Gross Profit, 3 Yr. CAGR %	-	-	-	71.11	87.33
EBITDA, 3 Yr. CAGR %	-	-	78.55	22.87	-39.13
EBITA, 3 Yr. CAGR %	-	-	79.56	24.37	-35.91
EBIT, 3 Yr. CAGR %	-	-	79.56	24.37	-35.91
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	62.15	12.76	-10.51
Net Income, 3 Yr. CAGR %	-	-	62.15	12.76	-10.51
Normalized Net Income, 3 Yr. CAGR %	-	-	79.54	12.81	-10.51
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	25.72	4.85	-12.45
Accounts Receivable, 3 Yr. CAGR %	-	-	-	44.9	-25.26
Inventory, 3 Yr. CAGR %	-	-	133.12	72.71	-22.65
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	153.73	73.55	-7.96
Total Assets, 3 Yr. CAGR %	-	-	171.31	-5.33	-24.46
Tangible Book Value, 3 Yr. CAGR %	-	-	257.59	-14.26	-23.76
Common Equity, 3 Yr. CAGR %	-	-	257.59	-14.26	-23.76
Cash From Operations, 3 Yr. CAGR %	-	-	73.8	16.78	6.1
Capital Expenditures, 3 Yr. CAGR %	-	-	116.11	-13.08	-68.94
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	14.27	-39.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	14.18	-39.06
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	1.64
EBITA, 5 Yr. CAGR %	-	-	-	-	4.85
EBIT, 5 Yr. CAGR %	-	-	-	-	4.85
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	2.91
Net Income, 5 Yr. CAGR %	-	-	-	-	2.91
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	9.44
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-11.77
Inventory, 5 Yr. CAGR %	-	-	-	-	28.66
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	57.38
Total Assets, 5 Yr. CAGR %	-	-	-	-	62.43
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	95.74
Common Equity, 5 Yr. CAGR %	-	-	-	-	95.74
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	28.29
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-19.08